Evaluation of Analgesic and Antipyretic Activity of Ethanolic Leaf Extract of Catharanthus roseus (Nayantara) in Experimental Animals
South Asian Research Journal of Natural Products,
Catharanthus roseus has traditionally been used for relieving pain and inflammation. Few studies have been done to scientifically evaluate its analgesic and anti-pyretic activity. Hence our aim was to evaluate the analgesic and anti-pyretic activity of leaves of Catharanthus roseus in experimental animals.
Objective: To evaluate the analgesic and antipyretic activity of Catharanthus roseus leaf extract in animal models.
Study Design: Experimental study of analgesic and antipyretic activity in animal models.
Place of Study: Department of Pharmacology, Assam Medical College & Hospital, Dibrugarh, Assam, India.
Methodology: We prepared ethanolic extract of the powdered leaves of Catharanthus roseus (CREE). 30 healthy albino mice (20-35 g) of either sex were assigned to five groups of six animals each and administered the vehicle or drug as follows - Group I or normal control (gum acacia 10 ml/kg), Group II (CREE 100 mg/kg), Group III (CREE 250 mg/kg), Group IV (CREE 500 MG/KG) and Group V (Aspirin 100mg/kg). We assessed analgesic activity by writhing following 0.6 % glacial acetic acid i.p. injection and recording reaction time in Eddy’s Hot Plate method. Thereafter, five groups of six Wistar albino rats each were treated with the above doses in Groups I - IV and Paracetamol 50 mg/kg in Group V following s.c. injection of 20% aqueous suspension of dried yeast at 20 ml/kg to induce fever. Rectal temperature (Celsius) for anti-pyretic activity was recorded. Quantitative variables were expressed as Mean ± SD and one way ANOVA followed by Tukey’s multiple comparison test were used for statistical analysis with P<0.05 at 95% confidence level.
Results: Writhing response was significantly decreased (P<0.05) in test groups compared to control with dose dependent effect. Reaction time of mice to thermal pain stimulus in test groups was significantly increased (P<0.05) over time in hot plate method. Significant temperature reduction was not observed in test groups compared to control. (P>0.05).
Conclusion: Ethanolic extract of leaves of Catharanthus roseus possesses significant analgesic but not anti-pyretic activity.
- Catharanthus roseus
- wistar rats
- swiss mice
How to Cite
Nejat N, Valdiani A, Cahill D, Tan YH, Maziah M, Abiri R. Ornamental exterior versus therapeutic interior of Madagascar periwinkle (Catharanthus roseus): The two faces of a versatile herb. Scientific World Journal. 2015;2015:982412. DOI: 10.1155/2015/982412 Epub 2015 Jan 15. PMID: 25667940; PMCID: PMC4312627
Roepke J, Salim V, Wu M, Thamm AM, Murata J, Ploss K, et al. Vinca drug components accumulate exclusively in leaf exudates of Madagascar periwinkle. Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15287-92. DOI: 10.1073/pnas.0911451107 Epub 2010 Aug 9. PMID: 20696903; PMCID: PMC2930567.
Pham HNT, Vuong QV, Bowyer MC, Scarlett CJ. Phytochemicals derived from Catharanthus roseus and their health benefits. Technologies. 2020; 8(4):80. DOI: 10.3390/technologies8040080
Vega-Ávila E, Cano-Velasco JL, Alarcón-Aguilar FJ, Fajardo Ortíz Mdel C, Almanza-Pérez JC, Román-Ramos R. Hypoglycemic Activity of Aqueous Extracts from Catharanthus roseus. Evid Based Complement Alternat Med. 2012; 2012:934258.
DOI: 10.1155/2012/934258 Epub 2012 Sep 27. PMID: 23056144; PMCID: PMC3463976.
Nammi S, Boini MK, Lodagala SD, Behara RB. The juice of fresh leaves of Catharanthus roseus Linn. reduces blood glucose in normal and alloxan diabetic rabbits. BMC Complement Altern Med. 2003 Sep 2;3:4.
DOI: 10.1186/1472-6882-3-4 Epub 2003 Sep 2. PMID: 12950994; PMCID: PMC194756.
Bnouham M, Ziyyat A, Mekhfi H, Tahri A, Legssyer A. Medicinal plants with potential antidiabetic activity— A review of ten years of herbal medicine research (1990– 2000). Int J Diabetes Metab. 2006:14(1):1-25
Omar F, Tareq AM, Alqahtani AM, Dhama, K, Sayeed MA, Emran, TB, et al. Plant-Based Indole Alkaloids: A Comprehensive Overview from a Pharmacological Perspective. Molecules 2021;26:2297.
Chauhan K, Sharma S, Rohatgi K, Chauhan B. Antihyperlipidemic and antioxidative efficacy of Catharanthus roseus Linn [Sadabahar] in streptozotocin induced diabetic rats. Asian Journal of Pharmaceutical and Health Sciences. 2011;2(1):235–43.
Naz S, Haq R, Aslam F, Ilyas S. Evaluation of antimicrobial activity of extracts of in vivo and in vitro grown Vinca rosea L. (Catharanthus roseus) against pathogens. Pak J Pharm Sci. 2015;28(3):849-53. PMID: 26004716.
Singh N, Pandey BR, Verma P. An overview of phytotherapeutic approach in prevention and treatment of Alzheimer’s Syndrome & Dementia. International Journal of Pharmaceutical Sciences and Drug Research 2011; 3(3):162–72
Agarwal S, Chettri N, Bisoyi S, A. Tazeen A, AB, Vedamurthy AB, V Krishna V, et al. Evaluation of In-vitro anthelminthic activity of Catharanthus roseus extract. International Journal of Pharmaceutical Sciences and Drug Research 2011; 3(3):211-3.
Pham HNT, Sakoff JA, Vuong QV, Bowyer MC, Scarlett CJ. Phytochemical, antioxidant, anti-proliferative and antimicrobial properties of Catharanthus roseus root extract, saponin-enriched and aqueous fractions. Mol Biol Rep. 2019 Jun;46(3):3265-73.
DOI: 10.1007/s11033-019-04786-8 Epub 2019 Apr 3. PMID: 30945069.
Pereira DM, F. Ferreres F, Oliveira JMA, Gaspar L, Faria J, Valentao P, et al. Pharmacological effects of Catharanthus roseus root alkaloids in acetylcholinesterase inhibition and cholinergic neurotransmission. Phytomedicine. 2010;17(8-9):646–52.
Nayak BS, Pinto Pereira LM. Catharanthus roseus flower extract has wound-healing activity in Sprague Dawley rats. BMC Complement Altern Med. 2006 Dec 21;6:41.
DOI: 10.1186/1472-6882-6-41 PMID: 17184528; PMCID: PMC1764761.
Hassan KA, Brenda AT, Patrick V, Patrick OE. In vivo antidiarrheal activity of the ethanolic leaf extract of Catharanthus roseus linn. (Apocyanaceae) in wistar rats. Afr J Pharm Pharmacol. 2011;5(15);1797–1800.
Johnson IS, Armstrong JG, Gorman M, Burnett JP. The vinca alkaloids: A new class of oncolytic agents. Cancer Res. 1963;23:1390-427.
Cragg GM, Newman DJ. Plants as a source of anticancer agents. J Ethnopharmacol. 2005;100(1-2):72–9.
Committee for the purpose of control and supervision of experimental animals. Compendium of CPCSEA. New Delhi: Ministry of Environment, Forests and Climate Change, Animal Welfare Division, Govt. of India. 2018;202.
Available from: http://cpcsea.nic.in/WriteReadData/userfiles/file/Compendium%20of%20CPCSEA.pdf
Accessed 11th June 2021
Azwanida NN. A review on the extraction methods use in medicinal plants, principle, strength, and limitation. Med Aromat Plants. 2015;4:196.
Chattopadhyay RR, Banerjee RN, Sarkar SK, Ganguly S, Basu TK. Antiinflammatory and acute toxicity studies with the leaves of Vinca rosea Linn in experimental animals. Ind J Physiol. Pharmacol.1992;36(4):291-2.
Ajuru MG, Ajuru G, Nmom FW, Worlu CW, Igoma PG. Acute toxicity study and determination of median lethal dose of Catharanthus roseus in Wistar albino rats. Journal of Applied Sciences 2019;19:217-22.
Koster R, Anderson M and De Beer J. Acetic acid for analgesic screening. Proc Soc Exp Biol Med.1959;18:412–417
Castagné V, Hernier, AM, Porsolt RD. CNS safety pharmacology. Reference Module in Biomedical Sciences 2014. Elsevier Inc; 2014.
Available:https://doi.org/10.1016/B978-0-12-801238-3.04931-X Accessed 27th June 2021
In Vogel, HG (Ed.). Drug discovery and evaluation pharmacological assays. 2nd ed. Springer-Verlag Berlin Heidelberg. 2002;716,772-4.
Garg VK, Saini D. Analgesic and antipyretic activity of ethanolic extract of leaves of Catharanthus roseus. Der Pharmacia Lettre. 2016;8(18): 48-52.
Ruiz-Miyazawa KW, Zarpelon AC, Pinho-Ribeiro FA, Pavao-de-souza GF, Casagrande R, Verri WA. Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-κB activation in the paw and spinal cord. PLoS One 2015 Mr 30;10(3):e0118942. DOI: 10.1371/journal.pone.0118942 PMID: 25822523; PMCID: PMC4379066.
Lourenco-Gonzalez Y, Fattori V, Domiciano TP, Rossaneis AC, Borghi SM, Zaninelli TH, et al. Hindawi Mediators of Inflammation. 2019;Article ID 6481812 Available from: https://doi.org/10.1155/2019/6481812 Accessed 14th June 2021
Ruiz-Miyazawa KW, Pinho-Ribeiro FA, Zarpelon AC, Staurengo-Ferrari L, Silva RL, Alves-Filho JC, et al. Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-κB. Chem Biol Interact. 2015 Jul 25;237: 9-17.
DOI: 10.1016/j.cbi.2015.05.007 Epub 2015 May 14. PMID: 25980587.
Jeon KI, Xu X, Aizawa T, Lim JH, Jono H, Kwon DS, et al. Vinpocetine inhibits NF-κB-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proc Natl Acad Sci USA. 2010;107(21):9795–800. DOI: 10.1073/pnas.0914414107 PMID: 20448200 PMCID: PMC2906898
Medina AE. Vinpocetine as a potent antiinflammatory agent. Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):9921-2. DOI: 10.1073/pnas.1005138107 Epub 2010 May 21. PMID: 20495091; PMCID: PMC2890434.
Abdel Salam OM. Vinpocetine and piracetam exert antinociceptive effect in visceral pain model in mice. Pharmacol Rep. 2006;58(5):680–91.
Csillik B, Mihaly A, Krisztin-Pe´va B, Farkas I, Knyiha´r-Csillik E. Mitigation of nociception via transganglionic degenerative atrophy: Possible mechanism of vinpocetine-induced blockade of retrograde axoplasmic transport. Ann Anat. 2008;190:140-5.
Csillik B, Mihály A, Knyihár-Csillik E. Antinociceptive effect of vinpocetine--a comprehensive survey. Ideggyogyaszati Szemle. 2010;63(5-6):185-92.
Zhang YS, Li JD, Yan C. An update on vinpocetine: New discoveries and clinical implications. Eur J Pharmacol. 2018 Jan 15;819:30-4. DOI: 10.1016/j.ejphar.2017.11.041 Epub 2017 Nov 26. PMID: 29183836; PMCID: PMC5766389.
Abstract View: 145 times
PDF Download: 24 times